Infinity Long Term Debt to Equity Trend from 2010 to 2022

INFI -  USA Stock  

USD 1.25  0.05  4.17%

Infinity Pharmaceuti Long Term Debt to Equity is decreasing over the last several years with slightly volatile swings. Long Term Debt to Equity is predicted to flatten to 0.27. During the period from 2010 to 2022 Infinity Pharmaceuti Long Term Debt to Equity regressed destribution of quarterly values had coefficient of variationof 146.26 and r-value of (0.61). Infinity Pharmaceuti Revenues is most likely to decrease significantly in the upcoming years. The last year's value of Revenues was reported at 1.55 Million. The current Research and Development Expense is estimated to increase to about 24.7 M, while Consolidated Income is projected to decrease to (50.2 M).

Infinity Historical Trends 

 
Refresh
Check Infinity Pharmaceuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Infinity main balance sheet or income statement drivers, such as Gross Profit of 1.6 M, Interest Expense of 2.2 M or Operating Expenses of 37.1 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.27, PPandE Turnover of 0.81 or Receivables Turnover of 761. Infinity financial statements analysis is a perfect complement when working with Infinity Pharmaceuti Valuation or Volatility modules. It can also supplement various Infinity Pharmaceuti Technical models. Please see the analysis of Infinity Pharmaceuti Correlation against competitors.

Infinity Long Term Debt to Equity Breakdown

Showing smoothed Long Term Debt to Equity of Infinity Pharmaceuti with missing and latest data points interpolated. Infinity Pharmaceuti's Long Term Debt to Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Infinity Pharmaceuti's overall financial position and show how it may be relating to other accounts over time.
Long Term Debt to Equity10 Years Trend
Decreasing
Slightly volatile
 Long Term Debt to Equity 
Share
      Timeline 

Infinity Long Term Debt to Equity Regression Statistics

Arithmetic Mean 0.57
Geometric Mean 0.33
Coefficient Of Variation 146.26
Mean Deviation 0.57
Median 0.23
Standard Deviation 0.83
Sample Variance 0.69
Range 2.23
R-Value(0.61)
Mean Square Error 0.47
R-Squared 0.37
Significance 0.028418
Slope(0.13)
Total Sum of Squares 8.24

Infinity Long Term Debt to Equity History

2012  0.20 
2016  0.23 
2021  0.27 

About Infinity Pharmaceuti Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Infinity Pharmaceuti income statement, its balance sheet, and the statement of cash flows. Infinity Pharmaceuti investors use historical funamental indicators, such as Infinity Pharmaceuti's Long Term Debt to Equity, to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Infinity Pharmaceuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Infinity Pharmaceuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Long Term Debt to Equity 0.27  0.27 
Average Equity-11.4 M-11.7 M
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Infinity Pharmaceuti Correlation against competitors. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.